在伴有核孔蛋白98（NUP98）融合基因的血液系统恶性肿瘤中，FLT3内部串联重复（FLT3-ITD）、威尔姆斯瘤基因1（WT1）和干细胞因子受体（KIT）同时发生突变的频率较高。 - Suppr

Suppr

超能文献

High frequencies of simultaneous FLT3-ITD, WT1 and KIT mutations in hematological malignancies with NUP98-fusion genes.

作者信息

Taketani T, Taki T, Nakamura T, Kobayashi Y, Ito E, Fukuda S, Yamaguchi S, Hayashi Y

出版信息

Leukemia. 2010 Nov;24(11):1975-7. doi: 10.1038/leu.2010.207. Epub 2010 Sep 23.

DOI:10.1038/leu.2010.207

PMID:20861915

Abstract

摘要

相似文献

High frequencies of simultaneous FLT3-ITD, WT1 and KIT mutations in hematological malignancies with NUP98-fusion genes.

Leukemia. 2010 Nov;24(11):1975-7. doi: 10.1038/leu.2010.207. Epub 2010 Sep 23.

Acute myeloid leukemia with NUP98-HOXC13 fusion and FLT3 internal tandem duplication mutation: case report and literature review.

Cancer Genet Cytogenet. 2009 Sep;193(2):98-103. doi: 10.1016/j.cancergencyto.2009.03.007.

Incidence and prognostic impact of c-Kit, FLT3, and Ras gene mutations in core binding factor acute myeloid leukemia (CBF-AML).

Leukemia. 2006 Jun;20(6):965-70. doi: 10.1038/sj.leu.2404188.

Quantitative monitoring of single nucleotide mutations by allele-specific quantitative PCR can be used for the assessment of minimal residual disease in patients with hematological malignancies throughout their clinical course.

Clin Chim Acta. 2011 Jan 14;412(1-2):53-8. doi: 10.1016/j.cca.2010.09.011. Epub 2010 Sep 16.

[Analysis of tyrosine kinases gene mutations in core binding factor related acute myeloid leukemia and its clinical significance].

Zhonghua Xue Ye Xue Za Zhi. 2011 Oct;32(10):679-83.

NUP98 is rearranged in 3.8% of pediatric AML forming a clinical and molecular homogenous group with a poor prognosis.

Leukemia. 2017 Mar;31(3):565-572. doi: 10.1038/leu.2016.267. Epub 2016 Oct 3.

Treatment of three pediatric AML co-expressing NUP98-NSD1, FLT3-ITD, and WT1.

BMC Pediatr. 2024 Jul 27;24(1):483. doi: 10.1186/s12887-024-04954-1.

FIP1L1-PDGFRalpha alone or with other genetic abnormalities reveals disease progression in chronic eosinophilic leukemia but good response to imatinib.

Chin Med J (Engl). 2008 May 20;121(10):867-73.

FLT3-TKD mutation in childhood acute myeloid leukemia.

Leukemia. 2003 May;17(5):883-6. doi: 10.1038/sj.leu.2402928.

Age-dependent frequencies of NPM1 mutations and FLT3-ITD in patients with normal karyotype AML (NK-AML).

Ann Hematol. 2012 Jan;91(1):9-18. doi: 10.1007/s00277-011-1280-6. Epub 2011 Jul 9.

引用本文的文献

Acute myeloid leukemia with NUP98::RARG rearrangement: a case report and review of the relevant literature.

Int J Hematol. 2025 Feb;121(2):265-271. doi: 10.1007/s12185-024-03881-2. Epub 2024 Dec 4.

NUP98 oncofusions in myeloid malignancies: An update on molecular mechanisms and therapeutic opportunities.

Hemasphere. 2024 Sep 25;8(9):e70013. doi: 10.1002/hem3.70013. eCollection 2024 Sep.

Mechanistic insights and potential therapeutic approaches for NUP98-rearranged hematologic malignancies.

Blood. 2020 Nov 12;136(20):2275-2289. doi: 10.1182/blood.2020007093.

Successful treatment of acute myeloid leukemia co-expressing NUP98/NSD1 and FLT3/ITD with preemptive donor lymphocyte infusions.

Int J Hematol. 2019 Oct;110(4):512-516. doi: 10.1007/s12185-019-02665-3. Epub 2019 May 27.

Acute WT1-positive promyelocytic leukemia with hypogranular variant morphology, bcr-3 isoform of PML-RARα and Flt3-ITD mutation: a rare case report.

Sao Paulo Med J. 2017 Mar-Apr;135(2):179-184. doi: 10.1590/1516-3180.2016.020104102016. Epub 2017 Jan 23.

Identification of MYC mutations in acute myeloid leukemias with NUP98-NSD1 translocations.

Leukemia. 2016 Jul;30(7):1621-4. doi: 10.1038/leu.2016.19. Epub 2016 Feb 9.

Acute monocytic leukaemia with t(11; 12) (p15; q13) chromosomal changes: A case report and literature review.

Oncol Lett. 2015 Oct;10(4):2307-2310. doi: 10.3892/ol.2015.3511. Epub 2015 Jul 20.

NUP98/NSD1 and FLT3/ITD coexpression is more prevalent in younger AML patients and leads to induction failure: a COG and SWOG report.

Blood. 2014 Oct 9;124(15):2400-7. doi: 10.1182/blood-2014-04-570929. Epub 2014 Aug 21.

The Impact of FLT3 Mutations on the Development of Acute Myeloid Leukemias.

Leuk Res Treatment. 2013;2013:275760. doi: 10.1155/2013/275760. Epub 2013 Jul 9.

POU1F1 is a novel fusion partner of NUP98 in acute myeloid leukemia with t(3;11)(p11;p15).

Mol Cancer. 2013 Jan 18;12:5. doi: 10.1186/1476-4598-12-5.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

High frequencies of simultaneous FLT3-ITD, WT1 and KIT mutations in hematological malignancies with NUP98-fusion genes.

作者信息

Taketani T, Taki T, Nakamura T, Kobayashi Y, Ito E, Fukuda S, Yamaguchi S, Hayashi Y

出版信息

Leukemia. 2010 Nov;24(11):1975-7. doi: 10.1038/leu.2010.207. Epub 2010 Sep 23.

DOI:10.1038/leu.2010.207

PMID:20861915

Abstract

摘要

相似文献

High frequencies of simultaneous FLT3-ITD, WT1 and KIT mutations in hematological malignancies with NUP98-fusion genes.

Leukemia. 2010 Nov;24(11):1975-7. doi: 10.1038/leu.2010.207. Epub 2010 Sep 23.

Acute myeloid leukemia with NUP98-HOXC13 fusion and FLT3 internal tandem duplication mutation: case report and literature review.

Cancer Genet Cytogenet. 2009 Sep;193(2):98-103. doi: 10.1016/j.cancergencyto.2009.03.007.

Incidence and prognostic impact of c-Kit, FLT3, and Ras gene mutations in core binding factor acute myeloid leukemia (CBF-AML).

Leukemia. 2006 Jun;20(6):965-70. doi: 10.1038/sj.leu.2404188.

Clin Chim Acta. 2011 Jan 14;412(1-2):53-8. doi: 10.1016/j.cca.2010.09.011. Epub 2010 Sep 16.

[Analysis of tyrosine kinases gene mutations in core binding factor related acute myeloid leukemia and its clinical significance].

Zhonghua Xue Ye Xue Za Zhi. 2011 Oct;32(10):679-83.

NUP98 is rearranged in 3.8% of pediatric AML forming a clinical and molecular homogenous group with a poor prognosis.

Leukemia. 2017 Mar;31(3):565-572. doi: 10.1038/leu.2016.267. Epub 2016 Oct 3.

Treatment of three pediatric AML co-expressing NUP98-NSD1, FLT3-ITD, and WT1.

BMC Pediatr. 2024 Jul 27;24(1):483. doi: 10.1186/s12887-024-04954-1.

FIP1L1-PDGFRalpha alone or with other genetic abnormalities reveals disease progression in chronic eosinophilic leukemia but good response to imatinib.

Chin Med J (Engl). 2008 May 20;121(10):867-73.

FLT3-TKD mutation in childhood acute myeloid leukemia.

Leukemia. 2003 May;17(5):883-6. doi: 10.1038/sj.leu.2402928.

Age-dependent frequencies of NPM1 mutations and FLT3-ITD in patients with normal karyotype AML (NK-AML).

Ann Hematol. 2012 Jan;91(1):9-18. doi: 10.1007/s00277-011-1280-6. Epub 2011 Jul 9.

引用本文的文献

Acute myeloid leukemia with NUP98::RARG rearrangement: a case report and review of the relevant literature.

Int J Hematol. 2025 Feb;121(2):265-271. doi: 10.1007/s12185-024-03881-2. Epub 2024 Dec 4.

NUP98 oncofusions in myeloid malignancies: An update on molecular mechanisms and therapeutic opportunities.

Hemasphere. 2024 Sep 25;8(9):e70013. doi: 10.1002/hem3.70013. eCollection 2024 Sep.

Mechanistic insights and potential therapeutic approaches for NUP98-rearranged hematologic malignancies.

Blood. 2020 Nov 12;136(20):2275-2289. doi: 10.1182/blood.2020007093.

Successful treatment of acute myeloid leukemia co-expressing NUP98/NSD1 and FLT3/ITD with preemptive donor lymphocyte infusions.

Int J Hematol. 2019 Oct;110(4):512-516. doi: 10.1007/s12185-019-02665-3. Epub 2019 May 27.

Acute WT1-positive promyelocytic leukemia with hypogranular variant morphology, bcr-3 isoform of PML-RARα and Flt3-ITD mutation: a rare case report.

Sao Paulo Med J. 2017 Mar-Apr;135(2):179-184. doi: 10.1590/1516-3180.2016.020104102016. Epub 2017 Jan 23.

Identification of MYC mutations in acute myeloid leukemias with NUP98-NSD1 translocations.

Leukemia. 2016 Jul;30(7):1621-4. doi: 10.1038/leu.2016.19. Epub 2016 Feb 9.

Acute monocytic leukaemia with t(11; 12) (p15; q13) chromosomal changes: A case report and literature review.

Oncol Lett. 2015 Oct;10(4):2307-2310. doi: 10.3892/ol.2015.3511. Epub 2015 Jul 20.

NUP98/NSD1 and FLT3/ITD coexpression is more prevalent in younger AML patients and leads to induction failure: a COG and SWOG report.

Blood. 2014 Oct 9;124(15):2400-7. doi: 10.1182/blood-2014-04-570929. Epub 2014 Aug 21.

The Impact of FLT3 Mutations on the Development of Acute Myeloid Leukemias.

Leuk Res Treatment. 2013;2013:275760. doi: 10.1155/2013/275760. Epub 2013 Jul 9.

POU1F1 is a novel fusion partner of NUP98 in acute myeloid leukemia with t(3;11)(p11;p15).

Mol Cancer. 2013 Jan 18;12:5. doi: 10.1186/1476-4598-12-5.